News

Partner companies' news

Anixa Biosciences' Ovarian Cancer CAR-T Therapy to be Discussed at The 4th International Workshop on CAR-T 2022
SAN JOSE, Calif. , April 6, 2022 /PRNewswire/ --  Anixa Biosciences, Inc. [1] (NASDAQ: ANIX), a biotechnology company focused on the treatment and ...
Acorn Management Partners, Administrator
— April 2022 — 427 views ANIX

Processa Pharmaceuticals Announces First Patient Enrolled in the PCS12852 Phase 2A Trial for the Treatment of Gastroparesis
HANOVER, MD, April 05, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage bioph...
Acorn Management Partners, Administrator
— April 2022 — 423 views PCSA

Motorsport Games Reports Fourth Quarter & Full Year 2021 Financial Results
MIAMI, March 30, 2022 (GLOBE NEWSWIRE) -- Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games” or the “Company”) today reported financial result...
Acorn Management Partners, Administrator
— April 2022 — 469 views MSGM

Processa Pharmaceuticals Announces Year-End 2021 Results and Provides Corporate Update
HANOVER, Md., March 30, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ("Processa" or the "Company"), a clinical stage compa...
Acorn Management Partners, Administrator
— April 2022 — 427 views PCSA

Anixa Biosciences Announces the Initiation of its Ovarian Cancer CAR-T Phase 1 Trial at Moffitt Cancer Center
SAN JOSE, Calif. , March 30, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. [1] (NASDAQ: ANIX), a biotechnology company focused on the treatment and...
Acorn Management Partners, Administrator
— April 2022 — 468 views ANIX

Motorsport Games’ rFactor 2 Becomes the Official Sim Racing Platform of Formula E
MIAMI, March 28, 2022 (GLOBE NEWSWIRE) -- None [1]*Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games”)* , a leading racing game developer, pub...
Acorn Management Partners, Administrator
— March 2022 — 502 views MSGM

Motorsport Games Partners with Romain Grosjean to Assist in the Development of rFactor 2 and esports Events
MIAMI, March 25, 2022 (GLOBE NEWSWIRE) -- None [1]*Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games”)* , a leading racing game developer, pub...
Acorn Management Partners, Administrator
— March 2022 — 462 views MSGM

Processa Pharmaceuticals To Host Conference Call to Discuss Fourth Quarter 2021 Results and Provide Drug Development Update on March 30 at 4:30 p.m. EST
HANOVER, MD, March 23, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical stage biopharmaceutical company developing...
Acorn Management Partners, Administrator
— March 2022 — 420 views PCSA

Anixa Biosciences to Participate in the 2022 Virtual Growth Conference Hosted by M-Vest, a Division of Maxim Group LLC
SAN JOSE, Calif. , March 17, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. [1] (NASDAQ: ANIX), a biotechnology company focused on the treatment and ...
Acorn Management Partners, Administrator
— March 2022 — 488 views ANIX

Motorsport Games to Report Fourth Quarter & Full Year 2021 Financial Results
MIAMI, March 16, 2022 (GLOBE NEWSWIRE) -- Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games”), a leading racing game developer, publisher and ...
Acorn Management Partners, Administrator
— March 2022 — 405 views MSGM

Processa Pharmaceuticals CEO Dr. David Young To Present at the Oppenheimer 32nd Annual Healthcare Conference
HANOVER, MD, March 10, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage bioph...
Acorn Management Partners, Administrator
— March 2022 — 438 views PCSA

Medexus to Participate in the 34th Annual Roth Conference
TORONTO and CHICAGO, March 09, 2022 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF) is pleas...
Acorn Management Partners, Administrator
— March 2022 — 486 views MEDXF

Medexus Pharmaceuticals Announces Deal for Gleolan in the United States
TORONTO and CHICAGO, March 01, 2022 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (*Medexus*) (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that it...
Acorn Management Partners, Administrator
— March 2022 — 454 views MEDXF

Motorsport Games Announces Next Gen Car For NASCAR 21: Ignition
MIAMI, Feb. 15, 2022 (GLOBE NEWSWIRE) -- None [1]*Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games”)* , a leading racing game developer, publ...
Acorn Management Partners, Administrator
— February 2022 — 493 views MSGM

Motorsport Games and Adam Breeden announce global agreement with Formula 1® to create next-level competitive socialising experience, launching in London in 2022
MIAMI, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Adam Breeden, the pioneer of competitive socialising in the UK and entrepreneurial force behind some of the...
Acorn Management Partners, Administrator
— February 2022 — 436 views MSGM

Medexus Pharmaceuticals Announces Normal Course Issuer Bid, or NCIB, for Convertible Debentures
TORONTO and CHICAGO, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (*Medexus*) (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that the...
Acorn Management Partners, Administrator
— February 2022 — 451 views MEDXF

Motorsport Games Announces rFactor 2 Content Update and User Interface Refresh
MIAMI, Feb. 07, 2022 (GLOBE NEWSWIRE) -- None [1]*Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games”)* , a leading racing game developer, publ...
Acorn Management Partners, Administrator
— February 2022 — 433 views MSGM

Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine
SAN JOSE, Calif., Jan. 25, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. [1]  (NASDAQ: ANIX), a biotechnology company focused on the treatment and ...
Acorn Management Partners, Administrator
— January 2022 — 530 views ANIX

Anixa Biosciences and MolGenie Announce Early Potency Analysis of SARS-CoV-2 Protease Inhibitor
SAN JOSE, Calif. and STUTTGART, Germany, Jan. 24, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. [1]  (NASDAQ: ANIX), a biotechnology company focuse...
Acorn Management Partners, Administrator
— January 2022 — 469 views ANIX

Clinical Evaluation Finds Arch Therapeutics’ AC5® Advanced Wound System Effective in Healing Complex Chronic Wounds in Patients with Previously Unsuccessful Treatments and Significant Comorbidities
FRAMINGHAM, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“*Arch*” or the “*Company*”), a marketer and developer o...
Acorn Management Partners, Administrator
— January 2022 — 454 views ARTH

About us

Helping America invest in you:

Connecting your company stock with professional market participants.

One call at a time

Stay updated :

Participate on our social stream.

Our Blogs

Tags

Archives